Parkside Financial Bank & Trust - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parkside Financial Bank & Trust ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$6,769
-31.8%
422
-1.4%
0.00%0.0%
Q2 2023$9,922
-0.4%
428
-0.2%
0.00%
-33.3%
Q1 2023$9,966
+167.3%
429
+66.9%
0.00%
+200.0%
Q4 2022$3,729
-25.4%
257
+3.2%
0.00%
-50.0%
Q3 2022$5,0000.0%2490.0%0.00%0.0%
Q2 2022$5,000
-28.6%
249
-6.0%
0.00%0.0%
Q1 2022$7,000
-30.0%
265
-25.4%
0.00%0.0%
Q4 2021$10,000
+11.1%
355
+32.0%
0.00%
-33.3%
Q3 2021$9,000
+12.5%
269
+0.4%
0.00%
+50.0%
Q2 2021$8,0000.0%268
+7.6%
0.00%0.0%
Q1 2021$8,000
+60.0%
2490.0%0.00%0.0%
Q4 2020$5,000
+150.0%
249
+112.8%
0.00%
+100.0%
Q3 2020$2,000
+100.0%
117
-6.4%
0.00%
Q2 2020$1,000
-66.7%
125
-38.4%
0.00%
-100.0%
Q1 2020$3,000
+50.0%
203
+150.6%
0.00%0.0%
Q4 2019$2,0000.0%81
+5.2%
0.00%0.0%
Q3 2019$2,000
+100.0%
77
+102.6%
0.00%
Q2 2019$1,000
-66.7%
38
-59.1%
0.00%
-100.0%
Q1 2019$3,000
+200.0%
93
+93.8%
0.00%
Q4 2018$1,000
-50.0%
480.0%0.00%
-100.0%
Q3 2018$2,0000.0%480.0%0.00%0.0%
Q2 2018$2,00048
+380.0%
0.00%
Q1 2018$0
-100.0%
10
-79.2%
0.00%
-100.0%
Q4 2017$2,0000.0%480.0%0.00%0.0%
Q3 2017$2,000
+100.0%
480.0%0.00%
Q2 2017$1,0000.0%48
-2.0%
0.00%
Q1 2017$1,000
-83.3%
49
-67.3%
0.00%
-100.0%
Q4 2015$6,0000.0%1500.0%0.00%0.0%
Q3 2015$6,0001500.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders